Posted in | News | Chemistry

Novozymes Joins Lignol Energy’s Consortium

Novozymes, an enzyme company and a global leader in bioinnovation, has become a member of Lignol Energy’s industrial consortium to carry out an ethanol project funded by Sustainable Development Technology Canada (SDTC).

Lignol Energy, a Canadian company, provides biorefining technologies for the production of biofuels and renewable chemicals.

As a part of the consortium, Novozymes will offer development and technical support to convert woody biomass into cost-competitive cellulosic ethanol. Both companies have successfully completed their R&D program. By partnering with Novozymes, Lignol has made a major advancement to produce cellulosic ethanol that is cost-effective with gasoline. Lignol recognizes Novozymes for its commitment towards the success of the consortium.

Combining Lignol’s highly reactive and clean substrates with Novozymes’ new enzymes is expected to create a convincing cost structure for commercial conversion of cellulose-to-ethanol.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Novozymes Joins Lignol Energy’s Consortium. AZoM. Retrieved on October 27, 2024 from https://www.azom.com/news.aspx?newsID=29625.

  • MLA

    Chai, Cameron. "Novozymes Joins Lignol Energy’s Consortium". AZoM. 27 October 2024. <https://www.azom.com/news.aspx?newsID=29625>.

  • Chicago

    Chai, Cameron. "Novozymes Joins Lignol Energy’s Consortium". AZoM. https://www.azom.com/news.aspx?newsID=29625. (accessed October 27, 2024).

  • Harvard

    Chai, Cameron. 2019. Novozymes Joins Lignol Energy’s Consortium. AZoM, viewed 27 October 2024, https://www.azom.com/news.aspx?newsID=29625.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.